BET inhibition triggers antitumor immunity by enhancing MHC class I expression in head and neck squamous cell carcinoma.
Zhang M, Wang G, Ma Z, Xiong G, Wang W, Huang Z, Wan Y, Xu X, Hoyle RG, Yi C, Hou J, Liu X, Chen D, Li J, Wang C.
Zhang M, et al. Among authors: wang g, wang w, wang c.
Mol Ther. 2022 Nov 2;30(11):3394-3413. doi: 10.1016/j.ymthe.2022.07.022. Epub 2022 Aug 3.
Mol Ther. 2022.
PMID: 35923111
Free PMC article.